These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25521201)

  • 21. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer.
    Duncavage E; Goodgame B; Sezhiyan A; Govindan R; Pfeifer J
    J Thorac Oncol; 2010 Nov; 5(11):1755-63. PubMed ID: 20975375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis.
    Tan X; Qin W; Zhang L; Hang J; Li B; Zhang C; Wan J; Zhou F; Shao K; Sun Y; Wu J; Zhang X; Qiu B; Li N; Shi S; Feng X; Zhao S; Wang Z; Zhao X; Chen Z; Mitchelson K; Cheng J; Guo Y; He J
    Clin Cancer Res; 2011 Nov; 17(21):6802-11. PubMed ID: 21890451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer.
    Campomenosi P; Gini E; Noonan DM; Poli A; D'Antona P; Rotolo N; Dominioni L; Imperatori A
    BMC Biotechnol; 2016 Aug; 16(1):60. PubMed ID: 27538962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis of microRNA expression in lung cancer.
    Võsa U; Vooder T; Kolde R; Vilo J; Metspalu A; Annilo T
    Int J Cancer; 2013 Jun; 132(12):2884-93. PubMed ID: 23225545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles.
    Yerukala Sathipati S; Ho SY
    Sci Rep; 2017 Aug; 7(1):7507. PubMed ID: 28790336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two lung development-related microRNAs, miR-134 and miR-187, are differentially expressed in lung tumors.
    Mirzadeh Azad F; Naeli P; Malakootian M; Baradaran A; Tavallaei M; Ghanei M; Mowla SJ
    Gene; 2016 Feb; 577(2):221-6. PubMed ID: 26642897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Machine learning identifies 10 feature miRNAs for lung squamous cell carcinoma.
    Ye Z; Sun B; Xiao Z
    Gene; 2020 Jul; 749():144669. PubMed ID: 32298761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.
    Raponi M; Dossey L; Jatkoe T; Wu X; Chen G; Fan H; Beer DG
    Cancer Res; 2009 Jul; 69(14):5776-83. PubMed ID: 19584273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of relationship between precursor of miRNA-944 and its mature form in lung squamous-cell carcinoma - the diagnostic value.
    Powrózek T; Mlak R; Dziedzic M; Małecka-Massalska T; Sagan D
    Pathol Res Pract; 2018 Mar; 214(3):368-373. PubMed ID: 29496309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
    Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
    Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer.
    Nymark P; Guled M; Borze I; Faisal A; Lahti L; Salmenkivi K; Kettunen E; Anttila S; Knuutila S
    Genes Chromosomes Cancer; 2011 Aug; 50(8):585-97. PubMed ID: 21563230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating Plasma miRNAs as Potential Biomarkers of Non-Small Cell Lung Cancer Obtained by High-Throughput Real-Time PCR Profiling.
    Niu Y; Su M; Wu Y; Fu L; Kang K; Li Q; Li L; Hui G; Li F; Gou D
    Cancer Epidemiol Biomarkers Prev; 2019 Feb; 28(2):327-336. PubMed ID: 30377207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation.
    White NM; Bao TT; Grigull J; Youssef YM; Girgis A; Diamandis M; Fatoohi E; Metias M; Honey RJ; Stewart R; Pace KT; Bjarnason GA; Yousef GM
    J Urol; 2011 Sep; 186(3):1077-83. PubMed ID: 21784468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma.
    Aushev VN; Zborovskaya IB; Laktionov KK; Girard N; Cros MP; Herceg Z; Krutovskikh V
    PLoS One; 2013; 8(10):e78649. PubMed ID: 24130905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA 92a-2*: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer.
    Ranade AR; Cherba D; Sridhar S; Richardson P; Webb C; Paripati A; Bowles B; Weiss GJ
    J Thorac Oncol; 2010 Aug; 5(8):1273-8. PubMed ID: 20548249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
    Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
    Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.